Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 2024Diseases of the EsophagusOpen Access

Neoadjuvant Immunotherapy Combined With Chemoradiotherapy vs Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Carcinoma (Cstageii-Iii): A Multi-Center Prospective Randomized Clinical Trial (Icross)

View Full Paper
Ask AI
Bookmark
Share

Authors

HJHeng Jiao

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Heng Jiao (2024) studied this question.

synapsesocial.com/papers/68e59e96b6db643587538effhttps://doi.org/10.1093/dote/doae057.378
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Neoadjuvant immuno-chemotherapy versus neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma2025
  2. 2Neoadjuvant immunotherapy combined with concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: A prospective, single-arm, phase II trial.2026
  3. 3474. NEOADJUVANT CHEMOIMMUNOTHERAPY VERSUS CHEMOTHERAPY PLUS ESOPHAGECTOMY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA: PRIMARY RESULT OF A RANDOMIZED CLINICAL TRIAL2025
  4. 4625. PHASE II TRIAL OF INDUCTION CHEMOTHERAPY FOLLOWED BY CHEMORADIATION AND MINIMALLY INVASIVE SURGERY FOR LOCALLY ADVANCED CARCINOMA OF THE ESOPHAGUS2024
  5. 5Preoperative radiotherapy in patients with locally advanced esophageal squamous cell carcinoma: a narrative review2025